DAY ONE BIOPHARMACEUTICALS Trademark

Trademark Overview

On Monday, December 9, 2019, a trademark application was filed for DAY ONE BIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the DAY ONE BIOPHARMACEUTICALS trademark a serial number of 88719563. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by Day One Therapeutics, Inc.. The DAY ONE BIOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, and neurological disorders
day one biopharmaceuticals

General Information

Serial Number88719563
Word MarkDAY ONE BIOPHARMACEUTICALS
Filing DateMonday, December 9, 2019
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6997035
Registration DateTuesday, March 7, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer, autoimmune disorders, and neurological disorders
Pseudo MarkDAY ONE BIOLOGICAL PHARMACEUTICALS; DAY 1 BIOLOGICAL PHARMACEUTICALS
NOT AVAILABLE"BIOPHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 12, 2019
Primary Code005
First Use Anywhere DateThursday, September 30, 2021
First Use In Commerce DateThursday, September 30, 2021

Trademark Owner History

Party NameDAY ONE BIOPHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameDAY ONE BIOPHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameDay One Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameDay One Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Thursday, December 12, 2019NEW APPLICATION ENTERED
Thursday, December 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 10, 2020ASSIGNED TO EXAMINER
Wednesday, March 11, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 11, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, March 11, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 11, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, March 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 18, 2020ASSIGNED TO LIE
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 11, 2020SOU TEAS EXTENSION RECEIVED
Friday, December 11, 2020SOU EXTENSION 1 FILED
Friday, December 11, 2020SOU EXTENSION 1 GRANTED
Tuesday, December 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 7, 2021SOU TEAS EXTENSION RECEIVED
Monday, June 7, 2021SOU EXTENSION 2 FILED
Monday, June 7, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 6, 2021SOU EXTENSION 3 FILED
Monday, December 6, 2021SOU EXTENSION 3 GRANTED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 3, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 3, 2022SOU EXTENSION 4 FILED
Friday, June 3, 2022SOU EXTENSION 4 GRANTED
Tuesday, June 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, December 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 15, 2022SOU EXTENSION 5 FILED
Thursday, December 15, 2022USE AMENDMENT FILED
Wednesday, January 4, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 19, 2023SOU EXTENSION 5 GRANTED
Thursday, January 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, January 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 31, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 1, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Friday, September 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 10, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 10, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

biopharmaceuticals disorders neurological autoimmune cancer preparations treatment pharmaceutical